Last reviewed · How we verify
NCT03233607: QUOTABL
Time of Postpartum Hemoglobin Assessment and Blood Loss During Delivery
trial testing Blood Draw in Hemorrhage, Postpartum in 100 participants. Completed in 23 April 2019.
4 January 2019
Quick facts
| Lead sponsor | Columbia University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 20 March 2018 |
| Primary completion | 4 January 2019 |
| Estimated completion | 23 April 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Blood Draw — full drug profile →
Conditions studied
- Hemorrhage, Postpartum — all drugs for Hemorrhage, Postpartum →
Sponsor
Columbia University
Who can join
Adults 18 to 65, female only, with Hemorrhage, Postpartum. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective cohort study of patients delivering at Columbia University Medical Center/ Allen Hospital. For the primary research question, the investigators will compare the change in maternal hemoglobin from postpartum day 1 to day 2 and also determine correlation with estimation of blood loss (EBL) and quantitative blood loss (QBL).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03233607
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood Draw
Trials testing the same drug.
- NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
- NCT06836141 — Biomarkers for Cognitive Decline in Intracerebral Hemorrhage · recruiting
- NCT06864819 — Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC · recruiting
- NCT06325644 — Well-Formulated Ketogenic Diet Polycystic Kidney Disease · NA · recruiting
- NCT06216704 — Skeletal Health and Bone Marrow Composition in Adolescents With Cystic Fibrosis · recruiting
Other recruiting trials for Hemorrhage, Postpartum
Currently open trials in the same condition.
- NCT06452355 — Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage · NA · recruiting
Other Columbia University trials
Trials by the same sponsor.
- NCT06558422 — Human Models of Selective Insulin Resistance: Pancreatic Clamp · Phase 1 · not yet recruiting
- NCT07264582 — HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking · NA · not yet recruiting
- NCT05992415 — Know Your Pressures NYC · NA · not yet recruiting
- NCT05645211 — The AgRP and GH/IGF-1 Axis in Children · not yet recruiting
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03233607 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Columbia University
- Last refreshed: 24 April 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03233607.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing